Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Medicus Pharma (Nasdaq: MDCX) Nears Surgery-Free Breakthrough in Oncology
October 10, 2025
Via
AB Newswire
Tickers
MDCX
Exposures
Product Safety
Nurix Stock Falls After-Hours After Wider Q3 Loss; Oppenheimer Sees FDA Support For Bexo, Retail Buys The Dip
October 09, 2025
Via
Stocktwits
Tickers
NRIX
Exposures
Product Safety
Why Cidara Therapeutics Stock Crushed It Today
October 09, 2025
Via
The Motley Fool
Tickers
CDTX
Exposures
Product Safety
Zoetis (NYSE:ZTS) Signals Robust Health with Q4 2025 Dividend Declaration, Bolstering Investor Confidence in Animal Health Sector
October 09, 2025
Via
MarketMinute
Topics
Economy
Tickers
ELAN
IDXX
MRK
ZTS
Exposures
Product Safety
Supply Chain
Cidara Therapeutics Granted FDA Breakthrough Therapy Designation For Flu-Preventing Antiviral
October 09, 2025
Via
Stocktwits
Tickers
CDTX
UWM
XBI
Exposures
Product Safety
Philip Morris Seeks FDA Approval To Keep IQOS Modified Risk Designation For Later Versions Of Device
October 08, 2025
Via
Stocktwits
Tickers
PM
Exposures
Product Safety
Government Shutdown Casts a Shadow: Economic Data Halted, Federal Reserve Navigates Blind
October 09, 2025
Via
MarketMinute
Topics
Bonds
Credit Cards
Economy
Tickers
ADP
COST
DHI
HD
JNJ
LEN
Exposures
Debt Markets
Economy
Interest Rates
Evolucian Introduces Humanity 2.0: A Fresh Perspective on Changing the World
October 09, 2025
Via
Get News
Topics
Product Recall
Exposures
Legal
Product Safety
Drugzone Strengthens Community Healthcare by Supporting Independent Pharmacies
October 09, 2025
Via
AB Newswire
Topics
Economy
Exposures
Product Safety
Supply Chain
Duos Secures $130 Million: AI-Powered Platform to Revolutionize Senior Health Navigation
October 09, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Lawsuit
Tickers
HUM
Exposures
Artificial Intelligence
Financial
Legal
Eli Lilly Completes Phase 1 Study for Bimagrumab and Tirzepatide Amidst Strategic Pipeline Revisions
October 09, 2025
Via
MarketMinute
Tickers
LLY
NVO
Exposures
Product Safety
Jefferies Initiates Beam Therapeutics with "Buy" Rating, Eyeing Promising Gene-Editing Pipeline and Upcoming Catalysts
October 09, 2025
Via
MarketMinute
Tickers
BEAM
Exposures
Product Safety
Regeneron's Libtayo Gains FDA Approval To Reduce Recurrence Risk In Skin Cancer Patients
October 09, 2025
Via
Benzinga
Tickers
REGN
Exposures
Product Safety
Market Giants Retreat: S&P 500 and Nasdaq Pull Back from Record Highs Amidst Economic Headwinds
October 09, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
Economy
Tickers
AEHR
ARM
BRK-A
BRK-B
COST
GOOGL
Exposures
Artificial Intelligence
Debt Markets
Economy
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Unicycive Therapeutics, Inc. (UNCY) Shareholders
October 09, 2025
Via
NewMediaWire
Topics
Fraud
Lawsuit
Tickers
UNCY
Exposures
Financial
Legal
Product Safety
Class Action Filed Against Cytokinetics, Incorporated (CYTK) Seeking Recovery for Investors - Contact Levi & Korsinsky
October 09, 2025
Via
NewMediaWire
Topics
Earnings
Fraud
Lawsuit
Tickers
CYTK
Exposures
Financial
Legal
Product Safety
Lost Money on Savara Inc. (SVRA)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
October 09, 2025
Via
NewMediaWire
Topics
Fraud
Lawsuit
Tickers
SVRA
Exposures
Financial
Legal
Product Safety
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Unicycive Therapeutics, Inc. (UNCY) Shareholders
October 09, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Tickers
UNCY
Exposures
Financial
Legal
Product Safety
Class Action Filed Against Cytokinetics, Incorporated (CYTK) Seeking Recovery for Investors - Contact Levi & Korsinsky
October 09, 2025
Via
TheNewswire.com
Topics
Earnings
Fraud
Lawsuit
Tickers
CYTK
Exposures
Financial
Legal
Product Safety
Lost Money on Savara Inc. (SVRA)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
October 09, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Tickers
SVRA
Exposures
Financial
Legal
Product Safety
Retail Buzz Builds Around Regeneron After FDA Clears Libtayo For High-Risk Skin Cancer; Traders Eye ‘Buying Opportunity’
October 08, 2025
Via
Stocktwits
Tickers
REGN
Exposures
Product Safety
MAGA Stocks Undercard: MYSE, XBIO, ATON, ACXP, RDZN – Innovators Driving Next Tech, Blockchain, AI Wave – More Stocks Inside
October 08, 2025
Via
AB Newswire
Topics
Artificial Intelligence
Intellectual Property
Tickers
ACXP
ATON
HIT
MYSE
RNAZ
XBIO
Exposures
Artificial Intelligence
Intellectual Property
Product Safety
MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) on the Beat of Cardiac Innovation
October 08, 2025
Via
Investor Brand Network
Topics
Intellectual Property
Tickers
BEAT
Exposures
Intellectual Property
Product Safety
BioMedNewsBreaks — NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Strengthens Pipeline with Dual Pathways for Ketamine-Based Therapies
October 08, 2025
Via
Investor Brand Network
Tickers
NRXP
Exposures
Product Safety
GM Reportedly Scraps Plan To Continue Offering EV Tax Credits
October 08, 2025
Via
Stocktwits
Tickers
F
GM
PM
VFMF
Exposures
Product Safety
Suki Ignites a New Era for Nursing with AI Consortium, Redefining Healthcare Workflows
October 08, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Tickers
AMWL
GOOGL
MSFT
ORCL
PINC
RUSH
Exposures
Artificial Intelligence
Product Safety
FDA Expands Johnson & Johnson Ulcerative Colitis Drug Approval To Pediatric Patients
October 08, 2025
Via
Benzinga
Tickers
JNJ
Exposures
Product Safety
Could Oral Osteoporosis Treatment Become the Next GLP-1-Style Blockbuster?
October 08, 2025
Via
AB Newswire
Tickers
COST
ENTX
Exposures
Product Safety
Ionis Pharmaceuticals (NASDAQ:IONS) Ascends to Six-Year High, Fueled by Breakthrough Pipeline and Robust Sales Outlook
October 08, 2025
Via
MarketMinute
Tickers
ALNY
AZN
BCRX
BIIB
BNTX
GS
Exposures
Product Safety
U.S. Government Shutdown Deepens Economic Uncertainty, Airports Face Mounting Strain
October 08, 2025
Via
MarketMinute
Topics
Bonds
Economy
Government
Tickers
AAL
BA
DAL
LMT
LUV
MRNA
Exposures
Debt Markets
Economy
Interest Rates
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today